Baxalta

Source: Wikipedia, the free encyclopedia.
Baxalta
Takeda Pharmaceutical Company
Websitewww.baxalta.com Edit this on Wikidata

Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound'[2]) is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division.[1] The company began its operation with a revenue of $6 billion,[3] and is now a subsidiary of Takeda Pharmaceutical Company.

Company history

Baxalta inherited all of its parent company's on-the-market treatments, focused on

Oncaspar from Sigma-Tau Finanziaria S.p.A. for US$900 million.[1][5]

In August 2015,

American Depositary Receipts for every share they hold, representing a premium of 36%, compared to the company's stock price on August 3.[8] This deal would create the largest global biotech company focused solely on rare diseases.[8]

In 2016 the company was acquired by Shire for $32 billion.[9] Subsequently, Shire was acquired by Takeda Pharmaceutical Company for $62 billion in January 2019.[10][11]

References

  1. ^ a b c Ben Reynolds. "Baxalta: A Rare Undervalued Biopharmaceutical Company". cnafinance.com. Archived from the original on 2015-07-24. Retrieved 2015-07-23.
  2. doi:10.4155/tde.14.103
    .
  3. ^ "Baxalta: Baxter's newly named biopharma spinout has had its ups and downs". FierceBiotech.
  4. Genetic Engineering & Biotechnology News
    (Paper). 35 (7): 10.
  5. ^ "Baxter Expands Cancer Therapies With $900M Oncaspar Buy". law360.com.
  6. ^ Tess Stynes (4 August 2015). "Shire Makes Unsolicited $30 Billion Bid for Baxalta". WSJ.
  7. ^ "Shire Offers $30B for Baxalta". GEN.
  8. ^ a b Kevin McCoy, USA TODAY (4 August 2015). "Pharma mania: Shire offers $30B for Baxalta". USA TODAY.
  9. ^ "Shire, Baxalta Tie the Knot in $32B Merger | GEN". Genengnews.com. 2016-01-11. Retrieved 2017-01-27.
  10. ^ "Takeda Completes Acquisition Of Shire". Asian Scientist Magazine | Science, technology and medical news updates from Asia. 2019-01-21. Retrieved 2019-01-23.
  11. ^ Minkoff, Yoel (2019-01-08). "Takeda Pharmaceutical completes Shire acquisition". Seeking Alpha. Retrieved 2019-01-23.


Stub icon

This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Baxalta&oldid=1222270803"